Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc) Purity >95%
SKU: PKSH034025-50
Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc) Purity >95%
| SKU # | PKSH034025 |
| Expression Host | HEK293 Cells |
Description
| Synonyms | BTNL9, Butyrophilin-like protein 9 |
| Species | Human |
| Expression Host | HEK293 Cells |
| Sequence | Ser35–Lys256 |
| Accession | Q6UXG8 |
| Calculated Molecular Weight | 52.0 kDa |
| Observed Molecular Weight | 55-70 kDa |
| Tag | C-Fc |
| Bio-activity | Not validated for activity |
Properties
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Reconstitution | Please refer to the printed manual for detailed information. |
Background
Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.